Upgrade to SI Premium - Free Trial

AstraZeneca (AZN) PT Raised to $42 at Bernstein; 'Catalyst-Rich Year'

February 5, 2018 7:44 AM
Bernstein raised its price target on AstraZeneca ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS View Analyst PT Change

Next Articles